Variant report

Variant	esv3375828
Chromosome Location	chr8:65492023-65494771
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:194)
CpG islands
(count:857)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:194 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BATF	chr8:65492200-65492535	GM12878	blood:	n/a	n/a
2	BCL11A	chr8:65492234-65492499	GM12878	blood:	n/a	n/a
3	BCLAF1	chr8:65492480-65492824	GM12878	blood:	n/a	chr8:65492769-65492778
4	BHLHE40	chr8:65493700-65494352	GM12878	blood:	n/a	n/a
5	BHLHE40	chr8:65492277-65493010	GM12878	blood:	n/a	n/a
6	CEBPB	chr8:65494440-65494708	H1-hESC	embryonic stem cell:	n/a	n/a
7	CEBPB	chr8:65494421-65494786	MCF-7	breast:	n/a	n/a
8	CHD1	chr8:65494053-65494609	H1-hESC	embryonic stem cell:	n/a	n/a
9	CHD1	chr8:65493406-65493604	H1-hESC	embryonic stem cell:	n/a	n/a
10	CHD1	chr8:65491785-65495139	GM12878	blood:	n/a	chr8:65492726-65492733
11	CHD2	chr8:65493985-65494085	GM12878	blood:	n/a	n/a
12	CHD2	chr8:65494069-65494262	H1-hESC	embryonic stem cell:	n/a	n/a
13	CHD2	chr8:65493408-65493757	GM12878	blood:	n/a	n/a
14	CHD2	chr8:65494356-65494927	GM12878	blood:	n/a	n/a
15	CHD2	chr8:65492149-65493115	GM12878	blood:	n/a	chr8:65492726-65492733
16	CTBP2	chr8:65492814-65494720	H1-hESC	embryonic stem cell:	n/a	n/a
17	CTCF	chr8:65494542-65494699	GM12878	blood:	n/a	n/a
18	CTCF	chr8:65493560-65493710	GM12873	blood:	n/a	n/a
19	CTCF	chr8:65493440-65493590	HEK293	kidney:	n/a	n/a
20	CTCF	chr8:65494200-65494350	GM12869	blood:	n/a	n/a
21	CTCF	chr8:65493680-65493830	GM12872	blood:	n/a	n/a
22	CTCF	chr8:65492160-65492310	GM12872	blood:	n/a	n/a
23	CTCF	chr8:65493360-65493510	GM12875	blood:	n/a	n/a
24	CTCF	chr8:65493320-65493470	GM12871	blood:	n/a	n/a
25	CTCF	chr8:65493440-65493590	GM12867	blood:	n/a	n/a
26	CTCF	chr8:65494000-65494150	GM12867	blood:	n/a	n/a
27	CTCF	chr8:65493492-65493622	GM10248	blood:	n/a	n/a
28	CTCF	chr8:65493674-65493704	GM10266	blood:	n/a	n/a
29	CTCF	chr8:65494101-65494318	GM12892	blood:	n/a	n/a
30	CTCF	chr8:65494128-65494229	GM19239	blood:	n/a	n/a
31	CTCF	chr8:65494266-65494279	GM12878	blood:	n/a	n/a
32	CTCF	chr8:65493541-65493557	GM19240	blood:	n/a	n/a
33	CTCF	chr8:65494160-65494310	GM12869	blood:	n/a	n/a
34	CTCF	chr8:65493440-65493590	GM12874	blood:	n/a	n/a
35	CTCF	chr8:65493420-65493570	GM12872	blood:	n/a	n/a
36	CTCF	chr8:65494120-65494290	GM12891	blood:	n/a	n/a
37	CTCF	chr8:65493500-65493650	GM12866	blood:	n/a	n/a
38	CTCF	chr8:65493489-65493588	GM19239	blood:	n/a	n/a
39	CTCF	chr8:65492300-65492450	GM12874	blood:	n/a	n/a
40	CTCF	chr8:65493440-65493590	GM12865	blood:	n/a	n/a
41	CTCF	chr8:65492747-65493031	GM12878	blood:	n/a	n/a
42	CTCF	chr8:65493440-65493590	GM12864	blood:	n/a	n/a
43	CTCF	chr8:65493398-65493753	GM12878	blood:	n/a	n/a
44	CTCF	chr8:65493460-65493610	GM12868	blood:	n/a	n/a
45	CTCF	chr8:65493440-65493620	GM19238	blood:	n/a	n/a
46	CTCF	chr8:65493460-65493610	GM12874	blood:	n/a	n/a
47	CTCF	chr8:65493465-65493581	GM12891	blood:	n/a	n/a
48	CTCF	chr8:65493460-65493610	GM12878	blood:	n/a	n/a
49	CTCF	chr8:65493540-65493690	GM12869	blood:	n/a	n/a
50	CTCF	chr8:65493440-65493590	GM06990	blood:	n/a	n/a

(count:857 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr8:65492727-65492777	HPAEpiC	pulmonary alveolar:	n/a
2	chr8:65492846-65492896	HRPEpiC	eye:	n/a
3	chr8:65492683-65492733	HNPCEpiC	eye:	n/a
4	chr8:65492727-65492777	HPAEpiC	pulmonary alveolar:	n/a
5	chr8:65492846-65492896	HRPEpiC	eye:	n/a
6	chr8:65492683-65492733	HNPCEpiC	eye:	n/a
7	chr8:65492570-65492620	NHBE	bronchial:	n/a
8	chr8:65492528-65492578	ovcar-3	ovarian:	n/a
9	chr8:65494451-65494501	GM12891	blood:	n/a
10	chr8:65492666-65492716	NHDF-neo	bronchial:	n/a
11	chr8:65492528-65492578	ECC-1	luminal epithelium:	n/a
12	chr8:65492280-65492330	K562	blood:	n/a
13	chr8:65494101-65494151	HCM	heart:	n/a
14	chr8:65494101-65494151	NB4	blood:	n/a
15	chr8:65492792-65492842	AG10803	skin:	n/a
16	chr8:65492727-65492777	SK-N-MC	brain:	n/a
17	chr8:65494451-65494501	HNPCEpiC	eye:	n/a
18	chr8:65492936-65492986	HRPEpiC	eye:	n/a
19	chr8:65492280-65492330	PrEC	prostate:	n/a
20	chr8:65494451-65494501	MCF10A-Er-Src	breast:	n/a
21	chr8:65492792-65492842	RPTEC	kidney:	n/a
22	chr8:65492534-65492584	LNCaP	prostate:	n/a
23	chr8:65492683-65492733	Caco-2	colon:	n/a
24	chr8:65492683-65492733	HEK293	kidney:	embryo
25	chr8:65492280-65492330	HRPEpiC	eye:	n/a
26	chr8:65492570-65492620	HAEpiC	amniotic membrane:	n/a
27	chr8:65492534-65492584	AG04449	skin:	fetal
28	chr8:65492570-65492620	HPAEpiC	pulmonary alveolar:	n/a
29	chr8:65494451-65494501	NH-A	brain:	n/a
30	chr8:65492936-65492986	GM12891	blood:	n/a
31	chr8:65492280-65492330	T-47D	breast:	n/a
32	chr8:65492280-65492330	NHDF-neo	bronchial:	n/a
33	chr8:65492528-65492578	HAEpiC	amniotic membrane:	n/a
34	chr8:65492666-65492716	K562	blood:	n/a
35	chr8:65492534-65492584	T-47D	breast:	n/a
36	chr8:65492936-65492986	NH-A	brain:	n/a
37	chr8:65494101-65494151	PrEC	prostate:	n/a
38	chr8:65492792-65492842	HUVEC	blood vessel:	n/a
39	chr8:65492615-65492665	BE2_C	brain:	n/a
40	chr8:65492528-65492578	HEEpiC	esophagus:	n/a
41	chr8:65492666-65492716	HIPEpiC	eye:	n/a
42	chr8:65494451-65494501	PANC-1	pancreas:	n/a
43	chr8:65492727-65492777	BE2_C	brain:	n/a
44	chr8:65492936-65492986	ECC-1	luminal epithelium:	n/a
45	chr8:65492846-65492896	Hela-S3	cervix:	n/a
46	chr8:65492615-65492665	AG04449	skin:	fetal
47	chr8:65492727-65492777	HRPEpiC	eye:	n/a
48	chr8:65492666-65492716	NHBE	bronchial:	n/a
49	chr8:65493706-65493756	AG09309	skin:	n/a
50	chr8:65493706-65493756	GM19239	blood:	n/a

No data

Variant related genes	Relation type
BHLHE22	TF binding region
ENSG00000254102	TF binding region
BHLHE22	CpG island
ENSG00000254102	CpG island

Extended variants
information (count: 115 )
Associated
traits (count: 97 )

Variant overlapped rSNPs/rCNVs (count:115 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs34738985	chr8:65492053-65492054	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
2	rs375141162	chr8:65492054-65492055	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
3	rs138055467	chr8:65492059-65492060	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
4	rs72155794	chr8:65492061-65492062	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
5	rs564949732	chr8:65492067-65492068	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
6	rs71260888	chr8:65492069-65492070	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
7	rs386726207	chr8:65492070-65492071	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
8	rs4737675	chr8:65492071-65492072	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
9	rs371341996	chr8:65492074-65492075	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
10	rs375953664	chr8:65492075-65492076	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
11	rs559821401	chr8:65492081-65492082	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
12	rs570938939	chr8:65492082-65492083	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
13	rs535149637	chr8:65492120-65492121	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
14	rs542397256	chr8:65492164-65492165	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
15	rs553211555	chr8:65492203-65492204	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
16	rs574538964	chr8:65492222-65492223	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
17	rs386726208	chr8:65492287-65492288	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
18	rs541667097	chr8:65492348-65492349	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
19	rs36033750	chr8:65492485-65492486	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
20	rs557174212	chr8:65492487-65492488	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
21	rs575192489	chr8:65492495-65492496	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
22	rs139234455	chr8:65492521-65492522	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
23	rs563773160	chr8:65492548-65492549	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
24	rs189871454	chr8:65492570-65492571	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
25	rs528154062	chr8:65492585-65492586	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
26	rs182034675	chr8:65492689-65492690	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
27	rs561647095	chr8:65492729-65492730	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
28	rs530275780	chr8:65492828-65492829	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
29	rs568001032	chr8:65492862-65492863	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
30	rs548502987	chr8:65492868-65492869	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
31	rs149988559	chr8:65492912-65492913	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs186173007	chr8:65492928-65492929	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs531264056	chr8:65492945-65492946	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
34	rs552579701	chr8:65492947-65492948	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
35	rs570829014	chr8:65492949-65492950	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
36	rs535029447	chr8:65493025-65493026	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs35739870	chr8:65493033-65493034	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs578248465	chr8:65493035-65493036	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs547029640	chr8:65493037-65493038	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs568463478	chr8:65493050-65493051	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs535635282	chr8:65493071-65493072	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs556916817	chr8:65493084-65493085	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs575177094	chr8:65493166-65493167	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs539378603	chr8:65493172-65493173	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs557653288	chr8:65493287-65493288	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs34256577	chr8:65493291-65493292	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs35315475	chr8:65493293-65493294	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs572474539	chr8:65493326-65493327	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs539859044	chr8:65493378-65493379	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs7016250	chr8:65493429-65493430	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:97)

Disease	PMID	Source
Cancer	16751803	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Ewing''s sarcoma	21437220	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Seminomas	18059402	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Pancreatic cancer	21811587	CNVD
Thyroid cancer	19087340	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	17603634	CNVD
Disorders of sex development	21048976	CNVD
Testicular cancer	18059402	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21509527	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Cancer	20164919	CNVD
primary effusion lymphomas	17116491	CNVD
Esophageal cancer	20955586	CNVD
Multiple myeloma	16461302	CNVD
abnormal development	18461090	CNVD
Cancer	20164920	CNVD
Oral cancer	21386901	CNVD
Uveal melanoma	21693616	CNVD
Langer-Giedion syndrome	22283845	CNVD
Cancer	21637783	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	20632083	CNVD
Breast cancer	19602461	CNVD
Cancer	22429812	CNVD
Endometrial cancer	22040021	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oral cancer	19627613	CNVD
Prostate cancer	21088497	CNVD
colon cancer	17210682	CNVD
Breast cancer	21264507	CNVD
Breast cancer	22028636	CNVD
Acute myeloid leukemia	16864856	CNVD
Salivary gland tumor	18059337	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Gastric cancer	17167181	CNVD
Colorectal cancer	19359472	CNVD
Breast cancer	16461572	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
head and neck squamous cell carcinoma	18028549	CNVD
Breast cancer	17001317	CNVD
Ewing''s sarcoma	17952124	CNVD
Urothelial carcinoma	21177765	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	16608533	CNVD
Metanephric adenoma	20802469	CNVD
Hepatocellular carcinoma	18803288	CNVD
Prostate cancer	18632612	CNVD
Glioblastoma multiforme	18628472	CNVD
Ovarian cancer	22174824	CNVD
Prostate cancer	16573809	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Colorectal cancer	16272173	CNVD
Melanoma	22183965	CNVD
Cancer	21949371	CNVD
Non-small cell lung cancer	21829676	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Acute myeloid leukemia	21358987	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Adenocarcinoma	21044232	CNVD
Squamous cell cancer	20885788	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
small cell lung cancer	20016488	CNVD
Sezary syndrome	18413736	CNVD
Colorectal cancer	21645411	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Autism	20531469	CNVD

Chromatin state (count:413 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:65487800-65492800	Bivalent/Poised TSS	Brain Inferior Temporal Lobe	brain
2	chr8:65488400-65492200	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
3	chr8:65489400-65492400	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
4	chr8:65490200-65492200	Weak transcription	Right Atrium	heart
5	chr8:65490200-65492400	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
6	chr8:65490400-65492600	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
7	chr8:65490800-65492800	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
8	chr8:65490800-65495000	Bivalent/Poised TSS	Duodenum Smooth Muscle	Duodenum
9	chr8:65491200-65492200	Weak transcription	Pancreas	Pancrea
10	chr8:65491200-65492400	Bivalent/Poised TSS	Brain Hippocampus Middle	brain
11	chr8:65491400-65492200	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
12	chr8:65491600-65492200	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
13	chr8:65491600-65492200	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
14	chr8:65491600-65492200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
15	chr8:65491600-65492600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
16	chr8:65491600-65493000	Bivalent/Poised TSS	Brain Angular Gyrus	brain
17	chr8:65491600-65494400	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
18	chr8:65491800-65492200	Flanking Bivalent TSS/Enh	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
19	chr8:65491800-65492200	Bivalent Enhancer	Adipose Nuclei	Adipose
20	chr8:65491800-65492200	Flanking Bivalent TSS/Enh	Brain Cingulate Gyrus	brain
21	chr8:65491800-65492200	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
22	chr8:65491800-65492200	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
23	chr8:65491800-65492400	Bivalent Enhancer	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr8:65491800-65492400	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
25	chr8:65491800-65492400	Bivalent/Poised TSS	Brain Substantia Nigra	brain
26	chr8:65491800-65492400	Flanking Bivalent TSS/Enh	GM12878-XiMat	blood
27	chr8:65491800-65492600	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
28	chr8:65491800-65492600	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
29	chr8:65491800-65492600	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood
30	chr8:65491800-65492600	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
31	chr8:65491800-65492600	Bivalent/Poised TSS	Rectal Smooth Muscle	rectum
32	chr8:65491800-65492600	Bivalent/Poised TSS	Stomach Smooth Muscle	stomach
33	chr8:65491800-65492800	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 1	blood
34	chr8:65491800-65493000	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
35	chr8:65491800-65493000	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
36	chr8:65491800-65494600	Bivalent/Poised TSS	Brain Dorsolateral Prefrontal Cortex	brain
37	chr8:65491800-65496000	Bivalent/Poised TSS	Fetal Brain Female	brain
38	chr8:65492000-65492200	Bivalent/Poised TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
39	chr8:65492000-65492200	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
40	chr8:65492000-65492200	Bivalent/Poised TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
41	chr8:65492000-65492200	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
42	chr8:65492000-65492200	Flanking Bivalent TSS/Enh	Fetal Brain Male	brain
43	chr8:65492000-65492400	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
44	chr8:65492000-65492400	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
45	chr8:65492000-65492400	Bivalent Enhancer	Liver	Liver
46	chr8:65492000-65492400	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
47	chr8:65492000-65492600	Bivalent Enhancer	NHEK	skin
48	chr8:65492000-65492800	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 2	blood
49	chr8:65492000-65492800	Bivalent/Poised TSS	Brain Anterior Caudate	brain
50	chr8:65492000-65493000	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links